4D Molecular Therapeutics Inc (FDMT)
25.66
+0.08
(+0.31%)
USD |
NASDAQ |
May 16, 16:00
25.66
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics Cash and Short Term Investments (Quarterly): 525.91M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 525.91M |
| December 31, 2023 | 288.23M |
| September 30, 2023 | 319.66M |
| June 30, 2023 | 310.34M |
| March 31, 2023 | 200.45M |
| December 31, 2022 | 213.55M |
| September 30, 2022 | 227.72M |
| June 30, 2022 | 241.09M |
| March 31, 2022 | 236.15M |
| Date | Value |
|---|---|
| December 31, 2021 | 247.78M |
| September 30, 2021 | 161.68M |
| June 30, 2021 | 243.74M |
| March 31, 2021 | 259.86M |
| December 31, 2020 | 276.73M |
| September 30, 2020 | 88.76M |
| December 31, 2019 | 49.65M |
| June 30, 2019 | 72.87M |
| December 31, 2018 | 91.76M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
49.65M
Minimum
Dec 2019
525.91M
Maximum
Mar 2024
233.19M
Average
241.09M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.206B |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |
| Theriva Biologics Inc | 18.26M |